Score Overview
See the full market ranking โ
Cumberland Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 37M to $ 44M and net income went from -$ 3M to -$ 2M. Revenue increased in 2 of those 5 years; net income in 1.
Across Cumberland Pharmaceuticals Inc's full reported history, from 2009 to 2025, revenue grew from $ 43M to $ 44M and net income went from $ 3M to -$ 2M. Revenue increased in 41% of the years measured; net income in 41%.
Cumberland Pharmaceuticals Inc currently holds a 5-year HDB Score of 2.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 7.91 | โ |
1 Year2025-08-12 | $ 1.78 | 344.18% |
5 Years2021-08-12 | $ 1.76 | 348.79% |
10 Years2016-08-12 | $ 2.72 | 190.46% |
All Time2009-08-11 | $ 10.30 | -23.20% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2009-08-11 |
|---|---|---|---|---|---|
| Price | $ 7.91 | $ 1.78 | $ 1.76 | $ 2.72 | $ 10.30 |
| Return | โ | 344.18% | 348.79% | 190.46% | -23.20% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 31M | -$ 10M | $ 3M |
| 2025 | $ 44M | -$ 2M | $ 11M |
| 2024 | $ 37M | -$ 6M | $ 17M |
| 2023 | $ 39M | -$ 6M | $ 18M |
| 2022 | $ 42M | -$ 5M | $ 19M |
| 2021 | $ 35M | -$ 3M | $ 27M |
| 2020 | $ 37M | -$ 3M | $ 24M |
| 2019 | $ 34M | -$ 3M | $ 28M |
| 2018 | $ 40M | -$ 6M | $ 36M |
| 2017 | $ 41M | -$ 7M | $ 50M |
| 2016 | $ 33M | -$ 944.68K | $ 50M |
| 2015 | $ 33M | $ 731.35K | $ 52M |
| 2014 | $ 36M | $ 2M | $ 54M |
| 2013 | $ 32M | -$ 2M | $ 54M |
| 2012 | $ 48M | $ 5M | $ 71M |
| 2011 | $ 51M | $ 5M | $ 70M |
| 2010 | $ 45M | $ 2M | $ 65M |
| IPO2009 | $ 43M | $ 3M | $ 78M |
Explore beyond CPIX
You're looking at Cumberland Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
